Chymozik Tablets serve as a clinically trusted anti-inflammatory and analgesic formulation that supports faster recovery from pain, swelling, and tissue injury. Amista Labs manufactures Chymozik Tablets with a potent enzymatic combination of Trypsin and Chymotrypsin (100000 Armour Units), which work synergistically to reduce inflammation, promote tissue repair, and enhance the body’s natural healing process.
Composition and Mechanism of Action
Each Chymozik Tablet is formulated with Trypsin & Chymotrypsin 100000 AU, which are proteolytic enzymes derived from natural sources. These enzymes help break down inflammatory proteins, fibrin clots, and necrotic tissue at the site of injury. By improving microcirculation and reducing edema, they accelerate the resolution of inflammation and support faster healing. Unlike conventional painkillers that mainly suppress symptoms, Chymozik Tablets actively assist the body’s repair mechanisms at a cellular level.
Therapeutic Uses
Chymozik Tablets are widely prescribed in medical and surgical practice for managing pain, swelling, and inflammation associated with various conditions. They are especially effective in post-operative recovery, trauma, sports injuries, fractures, sprains, and soft tissue injuries. The enzymatic action helps reduce post-surgical swelling, bruising, and discomfort, allowing patients to regain mobility and comfort more quickly. Orthopedic, dental, ENT, and general surgical cases often benefit from this formulation.
Benefits
-
Effectively reduces swelling and inflammation
-
Relieves pain associated with injury or surgery
-
Promotes faster healing of damaged tissues
-
Helps in the absorption of hematoma and edema
-
Supports recovery in trauma and post-surgical conditions
-
Well-tolerated with a favorable safety profile when used as directed
Dosage and Administration
Take Chymozik Tablets strictly as prescribed by the physician. Doctors generally advise patients to take the tablet on an empty stomach, or as directed, to ensure optimal enzyme absorption. Patients must not exceed the recommended dose and should complete the treatment for the duration advised by their healthcare provider.
Safety and Precautions
Chymozik Tablets are usually well tolerated. However, mild gastrointestinal discomfort such as nausea or bloating may occur in some individuals. Patients with known hypersensitivity to proteolytic enzymes should inform their doctor before use. Pregnant or breastfeeding women and patients with bleeding disorders should use this medication only under medical supervision.
Packaging and Quality Assurance
Chymozik Tablets come in 10×10 ALU-ALU blister packing, which ensures excellent product stability and protects the tablets from moisture and contamination. Amista Labs manufactures Chymozik Tablets in WHO-GMP, ISO, and GLP-certified facilities, ensuring strict compliance with international quality and safety standards.
Users Today : 19
Users Yesterday : 36
Users This Month : 286
Users This Year : 286
